EHC - European Haemophilia Consortium / LinkedIn
Dec 16, 2025, 00:32
New on EHCucate: Read about the “History of Replacement Factor Therapies” and More
European Haemophilia Consortium shared a post on LinkedIn:
“From fresh-frozen plasma in the 1950s to today’s extended and ultra-long half-life products—the evolution of replacement factor treatments for bleeding disorders showcases over 70 years of remarkable innovation and ingenuity, culminating in personalised therapy.
Want to dive deeper? Explore these new topics on the EHCucate webpage:
- History of Replacement Factor Therapies (RFT)
- Principles of Factor Replacement
- Practical Foundations of RFT
Learn more”
Follow the latest in Hemostasis Today.
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine
-
Apr 11, 2026, 13:10Danique Steeghs: Key Findings from a Microfluidic Chemiluminescent Thrombin Generation Assay
-
Apr 11, 2026, 13:06Shanvi Mahi: A Validated Tool to Explore Lived Experiences After Stroke Rehabilitation